Angiotensin II-induced migration of vascular smooth muscle cells is mediated by p38 mitogen-activated protein kinase-activated c-Src through spleen tyrosine kinase and epidermal growth factor receptor transactivation (Journal of Pharmacology and Experimental Therapeutics (2010) 332 (116-124))

B. E. Mugabe; F. A. Yaghini; C. Y. Song; C. K. Buharalioglu; C. M. Waters; K. U. Malik

Angiotensin II-induced migration of vascular smooth muscle cells is mediated by p38 mitogen-activated protein kinase-activated c-Src through spleen tyrosine kinase and epidermal growth factor receptor transactivation (Journal of Pharmacology and Experimental Therapeutics (2010) 332 (116-124))

B. E. Mugabe, F. A. Yaghini, C. Y. Song, C. K. Buharalioglu, C. M. Waters, K. U. Malik

Physiology

Research output: Contribution to journal › Comment/debate

Original language	English
Pages (from-to)	516-517
Number of pages	2
Journal	Journal of Pharmacology and Experimental Therapeutics
Volume	335
Issue number	2
State	Published - Nov 2010

ASJC Scopus subject areas

Molecular Medicine
Pharmacology

Fingerprint

Dive into the research topics of 'Angiotensin II-induced migration of vascular smooth muscle cells is mediated by p38 mitogen-activated protein kinase-activated c-Src through spleen tyrosine kinase and epidermal growth factor receptor transactivation (Journal of Pharmacology and Experimental Therapeutics (2010) 332 (116-124))'. Together they form a unique fingerprint.

Cite this

Mugabe, B. E., Yaghini, F. A., Song, C. Y., Buharalioglu, C. K., Waters, C. M., & Malik, K. U. (2010). Angiotensin II-induced migration of vascular smooth muscle cells is mediated by p38 mitogen-activated protein kinase-activated c-Src through spleen tyrosine kinase and epidermal growth factor receptor transactivation (Journal of Pharmacology and Experimental Therapeutics (2010) 332 (116-124)). Journal of Pharmacology and Experimental Therapeutics, 335(2), 516-517.

Mugabe, B. E. ; Yaghini, F. A. ; Song, C. Y. et al. / Angiotensin II-induced migration of vascular smooth muscle cells is mediated by p38 mitogen-activated protein kinase-activated c-Src through spleen tyrosine kinase and epidermal growth factor receptor transactivation (Journal of Pharmacology and Experimental Therapeutics (2010) 332 (116-124)). In: Journal of Pharmacology and Experimental Therapeutics. 2010 ; Vol. 335, No. 2. pp. 516-517.

@article{209f0f463b5949b7a45bf06828106f6f,

title = "Angiotensin II-induced migration of vascular smooth muscle cells is mediated by p38 mitogen-activated protein kinase-activated c-Src through spleen tyrosine kinase and epidermal growth factor receptor transactivation (Journal of Pharmacology and Experimental Therapeutics (2010) 332 (116-124))",

author = "Mugabe, {B. E.} and Yaghini, {F. A.} and Song, {C. Y.} and Buharalioglu, {C. K.} and Waters, {C. M.} and Malik, {K. U.}",

year = "2010",

month = nov,

language = "English",

volume = "335",

pages = "516--517",

number = "2",

}

Mugabe, BE, Yaghini, FA, Song, CY, Buharalioglu, CK, Waters, CM & Malik, KU 2010, 'Angiotensin II-induced migration of vascular smooth muscle cells is mediated by p38 mitogen-activated protein kinase-activated c-Src through spleen tyrosine kinase and epidermal growth factor receptor transactivation (Journal of Pharmacology and Experimental Therapeutics (2010) 332 (116-124))', Journal of Pharmacology and Experimental Therapeutics, vol. 335, no. 2, pp. 516-517.

Angiotensin II-induced migration of vascular smooth muscle cells is mediated by p38 mitogen-activated protein kinase-activated c-Src through spleen tyrosine kinase and epidermal growth factor receptor transactivation (Journal of Pharmacology and Experimental Therapeutics (2010) 332 (116-124)). / Mugabe, B. E.; Yaghini, F. A.; Song, C. Y. et al.
In: Journal of Pharmacology and Experimental Therapeutics, Vol. 335, No. 2, 11.2010, p. 516-517.

Research output: Contribution to journal › Comment/debate

TY - JOUR

T1 - Angiotensin II-induced migration of vascular smooth muscle cells is mediated by p38 mitogen-activated protein kinase-activated c-Src through spleen tyrosine kinase and epidermal growth factor receptor transactivation (Journal of Pharmacology and Experimental Therapeutics (2010) 332 (116-124))

AU - Mugabe, B. E.

AU - Yaghini, F. A.

AU - Song, C. Y.

AU - Buharalioglu, C. K.

AU - Waters, C. M.

AU - Malik, K. U.

PY - 2010/11

Y1 - 2010/11

UR - http://www.scopus.com/inward/record.url?scp=78149248969&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=78149248969&partnerID=8YFLogxK

M3 - Comment/debate

AN - SCOPUS:78149248969

SN - 0022-3565

VL - 335

SP - 516

EP - 517

JO - Journal of Pharmacology and Experimental Therapeutics

JF - Journal of Pharmacology and Experimental Therapeutics

IS - 2

ER -

Mugabe BE, Yaghini FA, Song CY, Buharalioglu CK, Waters CM, Malik KU. Angiotensin II-induced migration of vascular smooth muscle cells is mediated by p38 mitogen-activated protein kinase-activated c-Src through spleen tyrosine kinase and epidermal growth factor receptor transactivation (Journal of Pharmacology and Experimental Therapeutics (2010) 332 (116-124)). Journal of Pharmacology and Experimental Therapeutics. 2010 Nov;335(2):516-517.

Angiotensin II-induced migration of vascular smooth muscle cells is mediated by p38 mitogen-activated protein kinase-activated c-Src through spleen tyrosine kinase and epidermal growth factor receptor transactivation (Journal of Pharmacology and Experimental Therapeutics (2010) 332 (116-124))

ASJC Scopus subject areas

Other files and links

Fingerprint

Cite this